Waukesha, WI and Avon, CT – October 29, 2020 — Surfacide®, the leader in UV-C room decontamination, announced today its partnership with iCleanse, the leader in UV-C personal device decontamination, to combat the spread of COVID-19 in hospitals and healthcare environments and help protect essential healthcare and frontline workers in their workplace environments. Taking a multi-tiered approach to UV decontamination in healthcare and hospital facilities, this partnership will provide chemical-free hospital-grade UV-C technology critical to safeguarding those on the frontline to help combat this pandemic.
As the category leader in UV-C room decontamination and the world’s first and only patented, multiple-emitter UV-C system to safely reduce harmful bacteria and virus from hospital and patient environments, Surfacide recognizes the importance of adding innovative technologies to address disinfecting personal electronic devices commonly used in healthcare that are traveling from room to room, such as cell phones, tablets, and pagers. iCleanse’s patented technology complements Surfacide by offering a patented UV solution that effectively kills pathogens on personal electronic devices highly contaminated with bacteria and virus.
iCleanse Swift 5X
iCleanse Product Line to be Distributed by Surfacide
The iCleanse product line consists of multiple device sizes, including the Swift XL and Swift 5X, which are engineered to control the disinfection process and adaptable to a variety of locations throughout the healthcare facility. As the exclusive partner of the iCleanse product line in the healthcare market, Surfacide will distribute iCleanse disinfection products complementary to Surfacide’s Helios triple emitter UV-C system.
“We are excited to announce Surfacide’s partnership with iCleanse during these critical times when healthcare workers need hospital-grade decontamination technology they can trust,” said Gunner Lyslo, Founder and CEO of Surfacide. “Essential workers and patients need to be protected from viruses and bacteria that cause serious infections, including COVID-19. Our partnership with iCleanse provides additional key tools that are so critically needed during the pandemic.”
Chris Allen, CEO of iCleanse added, “We have a huge opportunity to showcase the effectiveness of our product, while we are all in this fight together to return to some normalcy after months of fighting the pandemic. Partnering with Surfacide will greatly help in protecting hospital staff, patients and visitors as we battle COVID-19.”
About Surfacide
Surfacide LLC and Surfacide Manufacturing Inc. are located in Waukesha, WI and produce multiple emitter UV-C systems. Surfacide is the only patented triple emitter UV-C system, providing the most efficient and flexible solution in the fight against viruses and bacteria that cause hospital-acquired infections. Hundreds of hospitals worldwide are using Surfacide technology to provide an extra layer of protection for patients and healthcare workers. Surfacide’s evidence-based UV-C solution reaches more surfaces, reduces shadowed areas, and requires less labor for a quicker turnaround time and better efficacy. Learn more about Surfacide by visiting https://surfacide.com or calling (844)-390-3538.
About iCleanse
iCleanse (formerly ReadyDock) is trusted by over 100 U.S. hospitals. The company’s chemical-free UV-C technology kills pathogens similar to COVID-19. Designed with clinicians and patients in mind, iCleanse offers a range of products for every workflow. iCleanse products disinfect high touch surfaces, such as mobile phones and tablets, as well as stethoscopes, ID badges, keycards, and many other items used daily. For more information, please visit: https://icleanse.com/.